China Medical Image Analysis Software Market Size, Trends, Share, Growth | Report 2023-2032
The China medical image analysis software market was surpassed at USD 422.83 million in 2022 and is expected to hit around USD 3,925.33 million by 2032, growing at a CAGR of 24.96% from 2023 to 2032.
Key Pointers
Report Scope of the China Medical Image Analysis Software Market
| Report Coverage | Details |
| Market Size in 2022 | USD 422.83 million |
| Revenue Forecast by 2032 | USD 3,925.33 million |
| Growth rate from 2023 to 2032 | CAGR of 24.96% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Companies Covered | Koninklijke Philips N.V.; Agfa-Gevaert Group; Canon Medical Systems; MIM Software Beijing Co., Ltd.; Bruker;Siemens Healthcare GmbH; ESAOTE SPA; Deepwise; Neusoft Medical Systems Co., Ltd.; Infervision Medical Technology. |
The primary growth drivers for this market include favorable government policies, the requirement for precise diagnosis & automation, growing demand for remote consultation, and advancements in medical imaging technology.
For instance, in recent years, the demand for online medical consultation and diagnosis has continuously increased, indicating a growing patient population in need of services provided by imaging cloud platforms. Patients can exchange medical images with experts via the cloud platform to conduct remote diagnoses, with experts subsequently doing AI-aided diagnoses on those images and providing digital reports or prescriptions to patients. As a result, this demonstrates the growing importance of digital images and cloud servers as the key technology required for AI-aided detection of lesion locations and online consultation.
Furthermore, in China, novel technologies are being used to combat the COVID-19 outbreak, positively supporting market growth. These technologies are based on AI algorithms, and analytics software, and also make use of drones to ensure efficient & timely hospital deliveries. Thus, the pandemic accelerated advancements in AI systems by including the potential to utilize these techniques. AI and radionics were used in conjunction with CT scans and X-rays as advanced imaging technologies in the detection as well as follow-up of COVID-19. For example, Zhongnan Hospital in China used AI to read CT scans and determine COVID-19 symptoms.
Additionally, companies utilized the COVID-19 pandemic as a point of challenge and introduced a wide range of products that would aid users throughout the pandemic, ultimately resulting in revenue growth for the company. For instance, in China in February 2020, AI-based company Infervision launched a coronavirus AI-powered system intended for frontline usage to help physicians efficiently diagnose and manage the condition. The Tongji Hospital in Wuhan, China, as well as other facilities such as the Third People's Hospital in Shenzhen, have all made use of the software.
The emerging AI technologies in the existing medical image system are indicative of high growth potential in the market. Innovation and integration of AI show potential opportunities for payers to meet healthcare demands with existing infrastructure. For instance, in 2019, Siemens Healthineers introduced SOMATOM go.Top, a 128-slice CT system. With a scanning speed of 0.33 seconds per revolution, it is built with integrated AI technology and is intended for rapid scans & related analysis. At the 31st International Medical Instruments and Equipment Exhibition, held in China, the company also unveiled the Biograph mMR PET/MRI system. Because of the system’s noise reduction software, it can produce clear images even when the patient is moving during the scan.
China Medical Image Analysis Software Market Segmentations:
By Software Type
By Modality
By Imaging Type
By Application
By End-use
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on China Medical Image Analysis Software Market
5.1. COVID-19 Landscape: China Medical Image Analysis Software Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. China Medical Image Analysis Software Market, By Software Type
8.1. China Medical Image Analysis Software Market, by Software Type, 2023-2032
8.1.1. Integrated Software
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Standalone Software
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. China Medical Image Analysis Software Market, By Modality
9.1. China Medical Image Analysis Software Market, by Modality, 2023-2032
9.1.1. Tomography
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Radiographic Imaging
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Combined Modalities
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. China Medical Image Analysis Software Market, By Imaging Type
10.1. China Medical Image Analysis Software Market, by Imaging Type, 2023-2032
10.1.1. 2D Imaging
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. 3D Imaging
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. 4D Imaging
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. China Medical Image Analysis Software Market, By Application
11.1. China Medical Image Analysis Software Market, by Application, 2023-2032
11.1.1. Orthopedic
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Dental
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Neurology
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Cardiology
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Oncology
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. Obstetrics & Gynecology
11.1.6.1. Market Revenue and Forecast (2020-2032)
11.1.7. Mammography
11.1.7.1. Market Revenue and Forecast (2020-2032)
11.1.8. Urology & Nephrology
11.1.8.1. Market Revenue and Forecast (2020-2032)
Chapter 12. China Medical Image Analysis Software Market, By End-use
12.1. China Medical Image Analysis Software Market, by End-use, 2023-2032
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Diagnostic Centers
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Others
12.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 13. China Medical Image Analysis Software Market, Regional Estimates and Trend Forecast
13.1. China
13.1.1. Market Revenue and Forecast, by Software Type (2020-2032)
13.1.2. Market Revenue and Forecast, by Modality (2020-2032)
13.1.3. Market Revenue and Forecast, by Imaging Type (2020-2032)
13.1.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.5. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 14. Company Profiles
14.1. Koninklijke Philips N.V.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agfa-Gevaert Group
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Canon Medical Systems
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. MIM Software Beijing Co., Ltd.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bruker
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Siemens Healthineers AG
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. ESAOTE SPA
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Deepwise
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Neusoft Medical Systems Co., Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Infervision Medical Technology Co., Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers